Leishmania species

Leishmania 101 - Sandfly's Surprise

• Vector: Female sandfly; transmits infective, flagellated promastigotes.
• Lifecycle: Promastigotes are phagocytosed by macrophages and transform into non-motile, intracellular amastigotes.
• Syndromes:
  • Cutaneous: Chronic, painless skin ulcers with indurated borders.
  • Mucocutaneous: Destructive lesions of the nose and mouth.
  • Visceral (Kala-azar): Spiking fevers, hepatosplenomegaly, pancytopenia, hypergammaglobulinemia.
• Treatment: Liposomal amphotericin B, sodium stibogluconate.

⭐ Diagnosis relies on identifying amastigotes within macrophages on a Giemsa-stained smear of bone marrow or spleen aspirate.

Lifecycle & Vector - A Bug's Journey

• Vector: Female sandfly (Phlebotomus or Lutzomyia species).
• Infective Form (to humans): Promastigote (motile, flagellated).
• Diagnostic Form (in humans): Amastigote (non-motile, intracellular) within macrophages.
• 📌 Mnemonic: Amastigotes are A-motile; Promastigotes are Pro-pelled.

⭐ Amastigotes, the intracellular form found within macrophages, are the key diagnostic finding on microscopic examination of tissue samples (e.g., skin biopsy, bone marrow).

Clinical Disease - The Three Faces

• 1. Cutaneous Leishmaniasis (CL):

  • L. tropica, L. major, L. mexicana
  • Presents as a painless, pink papule that enlarges into a nodule, then a well-demarcated ulcer with a raised, indurated border ("volcano sign").
  • Usually heals spontaneously, leaving a depigmented scar.

• 2. Mucocutaneous Leishmaniasis (MCL):

  • L. braziliensis
  • Occurs months to years after a cutaneous lesion.
  • Causes destructive, disfiguring lesions of the nasal septum, palate, and oropharyngeal mucosa (espundia).

• 3. Visceral Leishmaniasis (VL) / Kala-azar:

  • L. donovani, L. infantum
  • Systemic disease affecting the reticuloendothelial system.
  • Classic triad: Spiking fevers, massive splenomegaly, pancytopenia.
  • Associated with weight loss, weakness, and hyperpigmentation of the skin.

  ⭐ Diagnosis is confirmed by identifying amastigotes within macrophages in tissue specimens from bone marrow, spleen, or lymph node aspirates.

Diagnosis & Rx - Find and Fight

• Diagnosis:
  • Microscopy: Key is identifying intracellular amastigotes (LD bodies) within macrophages on Giemsa/Wright-stained tissue smears (e.g., spleen, bone marrow).
  • Culture: On Novy-MacNeal-Nicolle (NNN) medium.
  • PCR: For definitive species identification.
• Treatment:
  • Sodium stibogluconate: Traditional choice for cutaneous forms.
  • Liposomal Amphotericin B: Drug of choice for severe/visceral leishmaniasis.
  • Miltefosine: An effective oral agent.

⭐ Post-Kala-Azar Dermal Leishmaniasis (PKDL) can manifest as skin lesions months to years after successful visceral leishmaniasis treatment, acting as a disease reservoir.

High‑Yield Points - ⚡ Biggest Takeaways

• Leishmania is a protozoan transmitted by the sandfly; it exists as intracellular amastigotes in macrophages.
• Cutaneous leishmaniasis (L. tropica/mexicana) causes chronic, painless skin ulcers.
• Mucocutaneous leishmaniasis (L. braziliensis) leads to destructive lesions of the nose and mouth.
• Visceral leishmaniasis (L. donovani), or kala-azar, presents with fever, pancytopenia, and massive hepatosplenomegaly.
• Diagnosis relies on identifying amastigotes in tissue specimens.
• Key treatments include sodium stibogluconate and amphotericin B.